Loading market data...
Latest Top News
Show more
Dr Reddy’s Receives Health Canada Approval For Semaglutide Injection
Dr Reddy’s Laboratories has received approval from Health Canada for its semaglutide injection on April 29, 2026. The approval strengthens the company’s global pharmaceutical portfolio, enabling entry into Canada’s growing diabetes and obesity treatment market with a cost-effective alternative.
Stay Ahead – Explore Now! Hedge Fund Mars FX Collapse Sparks Global Hunt For $600 Million






